India scripts history with one billion vaccine doses administered

India could have probably reached this grand milestone earlier if precious time was not wasted by asking States to procure vaccines directly from the two manufacturers at a higher cost to vaccinate the 18-44 age group. India scripted history on October 21 when the number of COVID-19 vaccine doses administered across the country crossed the … Continue reading India scripts history with one billion vaccine doses administered

Advertisement

mRNA vaccine manufacturers loathe to share know-how

Moderna, which was funded $1 billion for research by the U.S. government, said in October 2020 that it will not enforce COVID-19-related patents against those making vaccines intended to combat the pandemic. But the company has refused to transfer technology to the South African hub to manufacture its mRNA vaccines for distribution to the African … Continue reading mRNA vaccine manufacturers loathe to share know-how

With nearly 45% vaccinated with one dose, India to finally resume exporting vaccines

India's decision to resume vaccine exports comes after the Government severely restricted exports in March and stopped them in mid-April. The renewed export drive will prioritise COVAX and neighbouring countries. In a welcome move to address the huge vaccine inequity globally, India will, from October, resume exporting much needed COVID-19 vaccines. The decision comes after the … Continue reading With nearly 45% vaccinated with one dose, India to finally resume exporting vaccines

As U.S approves booster shots, under 3.5% vaccinated in Africa

Of the nearly 6 billion doses administered globally, only 2% have been in Africa; about 80% have been administered in high- and upper-middle income countries. Less than 3.5% of people in Africa have been fully vaccinated so far compared with 54% of the total population in the U.S. Unkept promises of supplying vaccines to COVAX, … Continue reading As U.S approves booster shots, under 3.5% vaccinated in Africa

Serum’s supply to COVAX hit by India’s poor vaccination planning

While India approved Rs.3,000 crore in funding to Serum to meet the cost of ramping up production capacity only on April 19, 2021, Serum had received $300 million funding in August and September 2020 from the Gates Foundation to supply 200 million doses by first half of 2021. But only a paltry 19.8 million doses … Continue reading Serum’s supply to COVAX hit by India’s poor vaccination planning